Canada - engelsk - Health Canada

medican pharma incorporated - captopril - tablet - 12.5mg - captopril 12.5mg - angiotensin-converting enzyme inhibitors

Canada - engelsk - Health Canada

nu-pharm inc - captopril - tablet - 12.5mg - captopril 12.5mg - angiotensin-converting enzyme inhibitors

USA - engelsk - NLM (National Library of Medicine)

doh central pharmacy - captopril (unii: 9g64rsx1xd) (captopril - unii:9g64rsx1xd) - captopril 50 mg - captopril tablets are indicated for the treatment of hypertension. in using captopril, consideration should be given to the risk of neutropenia/agranulocytosis (see warnings ). captopril may be used as initial therapy for patients with normal renal function, in whom the risk is relatively low. in patients with impaired renal function, particularly those with collagen vascular disease, captopril should be reserved for hypertensives who have either developed unacceptable side effects on other drugs, or have failed to respond satisfactorily to drug combinations. captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. captopril tablets are indicated in the treatment of congestive heart failure usually in combination with diuretics and digitalis. the beneficial effect of captopril in heart failure does not require the presence of digitalis, however, most control

USA - engelsk - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - captopril (unii: 9g64rsx1xd) (captopril - unii:9g64rsx1xd), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - captopril 25 mg - captopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension. the blood pressure lowering effects of captopril and thiazides are approximately additive. this fixed combination drug may be used as initial therapy or substituted for previously titrated doses of the individual components. when captopril and hydrochlorothiazide are given together it may not be necessary to administer captopril in divided doses to attain blood pressure control at trough (before the next dose). also, with such a combination, a daily dose of 15 mg of hydrochlorothiazide may be adequate. treatment may, therefore, be initiated with captopril and hydrochlorothiazide tablets 25 mg/15 mg once daily. subsequent titration should be with additional doses of the components (captopril, hydrochlorothiazide) as single agents or as captopril and hydrochlorothiazide tablets 50 mg/15 mg, 25 mg/25 mg, or 50 mg/25 mg (see dosage and administration). in using captopril and hydrochlorothiazide, consideration should be give

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - captopril - oral tablet - 12.5mg

Irland - engelsk - HPRA (Health Products Regulatory Authority)

stada arzneimittel ag - captopril - tablets - 12.5mg milligram

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - captopril 12.5mg;  ;   - tablet - 12.5 mg - active: captopril 12.5mg     excipient: lactose monohydrate maize starch microcrystalline cellulose stearic acid

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

viatris limited - captopril 12.5mg - tablet - 12.5 mg - active: captopril 12.5mg excipient: lactose maize starch microcrystalline cellulose sodium starch glycolate stearic acid

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - captopril 12.5mg - tablet - 12.5 mg - active: captopril 12.5mg excipient: lactose monohydrate maize starch microcrystalline cellulose stearic acid

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - captopril 12.5mg (quantitative formula confidential to novopharm & moh) - tablet - 12.5 mg - active: captopril 12.5mg (quantitative formula confidential to novopharm & moh) excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose sodium laurilsulfate sodium starch glycolate starch